Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-49 av 49

2019
1 Bai, Baoyan; Vodák, Daniel; Nakken, Sigve; Wise, Jillian; Blaker, Yngvild Nuvin; Lingjærde, Ole Christian; Brodtkorb, Marianne; Hilden, Vera Irene; Trøen, Gunhild; Lorenz, Susanne; Lawrence, Michael S.; Myklebost, Ola; Meza, Leonardo Zepeda; Beiske, Klaus; Hovig, Eivind; Smeland, Erlend B; Holte, Harald; Myklebust, June Helen.
Deep profiling of genetic aberrations and clonal evolution in follicular lymphoma. Blood 2019 ;Volum 134.(1) s. 20-20
OUS UiB UiO Untitled
 
2 Huse, Kanutte; Wogsland, Cara Ellen; Polikowsky, Hannah G.; Diggins, Kirsten E.; Smeland, Erlend B; Myklebust, June; Irish, Jonathan Michael.
Human Germinal Center B Cells Differ from Naive and Memory B Cells in CD40 Expression and CD40L-Induced Signaling Response. Cytometry Part A 2019 ;Volum 95.(4) s. 442-449
OUS UiO Untitled
 
3 Josefsson, Sarah Elisabet; Beiske, Klaus; Blaker, Yngvild Nuvin; Førsund, Mette S; Holte, Harald; Østenstad, Bjørn; Kimby, Eva; Köksal, Hakan; Wälchli, Sébastien; Bai, Baoyan; Smeland, Erlend B; Levy, Ronald; Kolstad, Arne; Huse, Kanutte; Myklebust, June.
TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma. Cancer immunology research 2019 ;Volum 7.(3) s. 355-362
OUS UiO Untitled
 
4 Köksal, Hakan; Dillard, Pierre; Josefsson, Sarah Elisabet; Maggadottir, Solrun Melkorka; Pollmann, Sylvie Mireille; Fåne, Anne; Blaker, Yngvild Nuvin; Beiske, Klaus; Huse, Kanutte; Kolstad, Arne; Holte, Harald; Kvalheim, Gunnar; Smeland, Erlend B; Myklebust, June Helen; Inderberg, Else Marit; Wälchli, Sébastien.
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma. Blood Advances 2019 ;Volum 3.(8) s. 1230-1243
OUS UiO Untitled
 
5 Mensali, Nadia; Dillard, Pierre; Hebeisen, Michael; Lorenz, Susanne; Theodossiou, Theodossis; Myhre, Marit Renee; Fåne, Anne; Gaudernack, Gustav; Kvalheim, Gunnar; Myklebust, June; Inderberg, Else Marit; Wälchli, Sébastien.
NK cells specifically TCR-dressed to kill cancer cells. EBioMedicine 2019 ;Volum 40. s. 106-117
OUS UiO Untitled
 
6 Steen, Chloe Beate; Leich, Ellen; Myklebust, June Helen; Lockmer, Sandra; Wise, Jillian; Wahlin, Björn Engelbrekt; Østenstad, Bjørn; Liestøl, Knut; Kimby, Eva; Rosenwald, Andreas; Smeland, Erlend B; Holte, Harald; Lingjærde, Ole Christian; Brodtkorb, Marianne.
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy. Haematologica 2019 ;Volum 104.(10) s. 460-464
OUS UiO Untitled
 
2018
7 Holte, Harald; Beiske, Klaus; Boyle, Merrill; Trøen, Gunhild; Blaker, Yngvild Nuvin; Myklebust, June; Kvaløy, Anne Sunniva; Rosenwald, Andreas; Lingjærde, Ole Christian; Rimsza, Lisa M.; Smeland, Erlend B; Scott, David W.; Kolstad, Arne.
The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy. British Journal of Haematology 2018 s. 1-10
OUS SIV UiO Untitled
 
8 Våtsveen, Thea Kristin; Myhre, Marit Renee; Steen, Chloe Beate; Wälchli, Sébastien; Lingjærde, Ole Christian; Bai, Baoyan; Dillard, Pierre; Theodossiou, Theodossis; Holien, Toril; Sundan, Anders; Inderberg, Else Marit; Smeland, Erlend B; Myklebust, June; Oksvold, Morten Pedersen.
Artesunate shows potent anti-tumor activity in B-cell lymphoma. Journal of Hematology & Oncology 2018 ;Volum 11:23. s. 1-12
NTNU OUS STO UiO Untitled
 
2017
9 Bollum, Lise Kristin; Huse, Kanutte; Oksvold, Morten Pedersen; Bai, Baoyan; Hilden, Vera Irene; Forfang, Lise; Yoon, So; Wälchli, Sébastien; Smeland, Erlend B; Myklebust, June.
BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-β receptor type I ALK5. PLOS ONE 2017 ;Volum 12.(5)
OUS UiO Untitled
 
10 Inderberg, Else Marit; Mensali, Nadia; Oksvold, Morten Pedersen; Fallang, Lars Egil; Fåne, Anne; Skorstad, Gjertrud; Stenvik, Grethe-Elisabeth; Progida, Cinzia; Bakke, Oddmund; Kvalheim, Gunnar; Myklebust, June; Wälchli, Sébastien.
Human c-SRC kinase (CSK) overexpression makes T cells dummy. Cancer Immunology and Immunotherapy 2017 ;Volum 67.(4) s. 525-536
OUS UiO Untitled
 
11 Josefsson, Sarah Elisabet Göthberg; Huse, Kanutte; Kolstad, Arne; Beiske, Klaus; Pende, Daniela; Steen, Chloe Beate; Inderberg, Else Marit; Lingjærde, Ole Christian; Østenstad, Bjørn; Smeland, Erlend B; Levy, Ronald; Irish, Jonathan M.; Myklebust, June.
T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling. Clinical Cancer Research 2017 ;Volum 24.(4) s. 870-881
OUS UiO Untitled
 
12 Myklebust, June; Brody, Joshua; Kohrt, Holbrook E.; Kolstad, Arne; Czerwinski, Debra K; Waelchli, Sebastien; Green, Michael R.; Trøen, Gunhild; Liestøl, Knut; Beiske, Klaus; Houot, Roch; Delabie, Jan; Alizadeh, Ash A.; Irish, Jonathan M.; Levy, Ronald.
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling. Blood 2017 ;Volum 129.(6) s. 759-770
OUS UiO Untitled
 
13 Taraldsrud, Eli; Aukrust, Pål; Jørgensen, Silje Fjellgård; Lingjærde, Ole Christian; Olweus, Johanna; Myklebust, June; Fevang, Børre.
Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency. Clinical Immunology 2017 ;Volum 175. s. 69-74
OUS UiO Untitled
 
14 Taraldsrud, Eli; Fevang, Børre; Jørgensen, Silje Fjellgård; Moltu, Kristine; Hilden, Vera Irene; Tasken, Kjetil; Aukrust, Pål; Myklebust, June; Olweus, Johanna.
Defective IL-4 signaling in T cells defines severe common variable immunodeficiency. Journal of Autoimmunity 2017 ;Volum 81. s. 110-119
OUS UiO Untitled
 
15 Wogsland, Cara Ellen; Greenplate, Allison Rae; Kolstad, Arne; Myklebust, June; Irish, Jonathan Michael; Huse, Kanutte.
Mass cytometry of follicular lymphoma tumors reveals intrinsic heterogeneity in proteins including HLA-DR and a deficit in nonmalignant plasmablast and germinal center B-cell populations. Cytometry Part B: Clinical Cytometry 2017 ;Volum 92.(1) s. 79-87
OUS UiO Untitled
 
2016
16 Blaker, Yngvild Nuvin; Spetalen, Signe; Eide, Marianne Brodtkorb; Lingjærde, Ole Christian; Beiske, Klaus; Østenstad, Bjørn; Sander, Birgitta; Wahlin, Björn Engelbrekt; Melen, Christopher Michael; Myklebust, June; Holte, Harald; Delabie, Jan; Smeland, Erlend B.
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era. British Journal of Haematology 2016 ;Volum 175.(1) s. 102-114
OUS UiO Untitled
 
17 Holm, Kristine Lillebø; Indrevær, Randi Larsen; Myklebust, June; Kolstad, Arne; Moskaug, Jan Øivind; Naderi, Elin Hallan; Blomhoff, Heidi Kiil.
Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis. Immunology 2016 ;Volum 149.(1) s. 62-73
OUS UiO Untitled
 
2015
18 Blix, Egil Støre; Kildal, Anders Benjamin; Bertelsen, Eirin Listau; Waage, Anders; Myklebust, June; Kolstad, Arne; Husebekk, Anne.
Content of endothelial progenitor cells in autologous stem cellgrafts predict survival after transplantation for multiplemyeloma. Biology of Blood and Marrow Transplantation 2015 ;Volum 21.(5) s. 840-847
NTNU OUS STO UiT UNN Untitled
 
19 Oksvold, Morten Pedersen; Duyvestyn, Johanna M.; Dagger, Samantha A.; Taylor, Samuel J.; Forfang, Lise; Myklebust, June; Smeland, Erlend B; Langdon, Wallace Y..
The targeting of human and mouse B lymphocytes by dasatinib. Experimental Hematology 2015 ;Volum 43.(5) s. 352-363.e4
OUS UiO Untitled
 
20 Rein, Idun Dale; Stokke, Caroline; Jalal, Marwa; Myklebust, June; Patzke, Sebastian; Stokke, Trond.
New distinct compartments in the G2 phase of the cell cycle defined by the levels of γH2AX.. Cell Cycle 2015 ;Volum 14.(20) s. 3261-3269
OSLOMET OUS UiO Untitled
 
2014
21 Brodtkorb, Marianne; Lingjærde, Ole Christian; Huse, Kanutte; Trøen, Gunhild; Hystad, Marit Elise; Hilden, Vera Irene; Myklebust, June; Leich, Ellen; Rosenwald, Andreas; Delabie, Jan; Holte, Harald; Smeland, Erlend B.
Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma. Blood 2014 ;Volum 123.(7) s. 1051-1054
OUS UiO Untitled
 
2013
22 Arita, Adriana; McFarland, Daniel C.; Myklebust, June; Parekh, Samir; Petersen, Bruce; Gabrilove, Janice; Brody, Joshua D..
Signaling pathways in lymphoma: pathogenesis and therapeutic targets. Future Oncology 2013 ;Volum 9.(10) s. 1549-1571
OUS UiO Untitled
 
23 Green, Michael R.; Gentles, Andrew J.; Nair, Ramesh V.; Irish, Jonathan M.; Kihira, Shingo; Liu, Chih Long; Kela, Itai; Hopmans, Erik S.; Myklebust, June; Ji, Hanlee; Plevritis, Sylvia K.; Levy, Ronald; Alizadeh, Ash A..
Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 2013 ;Volum 121.(9) s. 1604-1611
OUS Untitled
 
24 Myklebust, June; Irish, Jonathan M.; Brody, Joshua; Czerwinski, Debra K; Houot, Roch; Kohrt, Holbrook E.; Timmerman, John; Said, Jonarhan; Green, Michael R.; Delabie, Jan; Kolstad, Arne; Alizadeh, Ash A.; Levy, Ronald.
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells. Blood 2013 ;Volum 121.(8) s. 1367-1376
OUS UiO Untitled
 
2012
25 Bakkebø, Maren; Huse, Kanutte; Hilden, Vera Irene; Forfang, Lise; Myklebust, June; Smeland, Erlend B; Oksvold, Morten Pedersen.
SARA is dispensable for functional TGF-beta signaling. FEBS Letters 2012 ;Volum 586.(19) s. 3367-3372
OUS UiO Untitled
 
26 Blix, Egil Støre; Irish, Jonathan M.; Husebekk, Anne; Delabie, Jan; Forfang, Lise; Tierens, Anne; Myklebust, June; Kolstad, Arne.
Phospho-spesific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma. BMC Cancer 2012 ;Volum 12.(478)
OUS UiT UNN Untitled
 
27 Blix, Egil Støre; Irish, Jonathan M.; Husebekk, Anne; Delabie, Jan; Tierens, Anne; Myklebust, June; Kolstad, Arne.
Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients. British Journal of Haematology 2012 ;Volum 159.(5) s. 604-608
OUS UiT UNN Untitled
 
28 Huse, Kanutte; Bakkebø, Maren; Waelchli, Sebastien; Oksvold, Morten Pedersen; Hilden, Vera Irene; Forfang, Lise; Bredahl, May K. Lyamouri; Liestøl, Knut; Alizadeh, Ash A.; Smeland, Erlend B; Myklebust, June.
Role of Smad Proteins in Resistance to BMP-Induced Growth Inhibition in B-Cell Lymphoma. PLOS ONE 2012 ;Volum 7.(10) s. -
OUS UiO Untitled
 
2011
29 Alizadeh, Ash A.; Gentles, Andrew J.; Alencar, Alvaro J.; Liu, Chih Long; Kohrt, Holbrook E.; Houot, Roch; Goldstein, Matthew J.; Zhao, Shuchun; Natkunam, Yasodha; Advani, Ranjana H.; Gascoyne, Randy D.; Briones, Javier; Tibshirani, Robert; Myklebust, June; Plevritis, Sylvia K.; Lossos, Izidore S.; Levy, Ronald.
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. Blood 2011 ;Volum 118.(5) s. 1350-1358
OUS UiO Untitled
 
30 Huse, Kanutte; Bakkebø, Maren Kolltveit; Oksvold, Morten Pedersen; Forfang, Lise; Hilden, Vera Irene; Stokke, Trond; Smeland, Erlend B; Myklebust, June.
Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: Differential effects of BMP-6 and BMP-7. European Journal of Immunology 2011 ;Volum 41.(11) s. 3135-3145
OUS UiO Untitled
 
31 Tkacz-Stachowska, Kinga Magda; Lund-Andersen, Christin; Velissarou, Angeliki; Myklebust, June; Stokke, Trond; Syljuåsen, Randi G..
The amount of DNA damage needed to activate the radiation-induced G2 checkpoint varies between single cells. Radiotherapy and Oncology 2011 ;Volum 101.(1) s. 24-27
OUS Untitled
 
2010
32 Chao, Mark P.; Alizadeh, AA; Tang, C; Myklebust, June; Varghese, B; Gill, S; Jan, M; Cha, AC; Chan, CK; Tan, BT; Park, CY; Zhao, FF; Kohrt, HE; Malumbres, R; Briones, J; Gascoyne, RD; Lossos, IS; Levy, R; Weissman, IL; Majeti, R.
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma. Cell 2010 ;Volum 142.(5) s. 699-713
OUS UiO Untitled
 
33 Huse, Kanutte; Bakkebø, Maren; Forfang, Lise; Hilden, Vera Irene; Smeland, Erlend B; Myklebust, June.
Bone Morphogenetic Proteins Inhibit CD40L-and IL-21-Induced Ig Production In Human B Cells: Differential Effects of BMP-6 and BMP-7. Blood 2010 ;Volum 116.(21) s. 729-729
OUS Untitled
 
34 Irish, Jonathan Michael; Myklebust, June; Alizadeh, Ash A.; Houot, Roch; Sharman, Jeff; Czerwinski, Debra K; Nolan, Garry P.; Levy, Ronald.
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression.. Proceedings of the National Academy of Sciences of the United States of America 2010 ;Volum 127.(29) s. 12747-12754
UiO Untitled
 
35 Myklebust, June; Irish, Jonathan Michael; Brody, Joshua; Alizadeh, Ash A.; Czerwinski, Debra; Houot, Roch; Kohrt, Holbrook E.; Kolstad, Arne; Levy, Ronald.
NF-kappa B Signaling In Response to CpG Stratifies Mantle Cell Lymphoma Patient Outcome. Blood 2010 ;Volum 116.(21) s. 67-68
OUS Untitled
 
2009
36 Gentles, Andrew J.; Alizadeh, Ash A.; Lee, SI; Myklebust, June; Shachaf, CM; Shahbaba, B; Levy, Ronald; Koller, David; Plevritis, Sylvia K..
A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients. Blood 2009 ;Volum 114.(15) s. 3158-3166
UiO Untitled
 
37 Houot, Roch; Goldstein, Matthew J.; Kohrt, Holbrook E.; Myklebust, June; Alizadeh, Ash A.; Lin, Jack T.; Irish, Jonathan M.; Torchia, James A.; Kolstad, Arne; Chen, Lieping; Levy, Ronald.
Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T-reg depletion. Blood 2009 ;Volum 114.(16) s. 3431-3438
OUS Untitled
 
38 Luo, RF; Zao, S; Tibshirani, Robert; Myklebust, June; Sanyal, M; Fernandez, Rosemary; Gratzinger, D; Marinelli, RJ; Lu, ZS; Wong, A; Levy, Ronald; Levy, sosh; Natkunam, Yasodha.
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. Human Pathology 2009 ;Volum 41.(2) s. 271-280
UiO Untitled
 
39 Myklebust, June; Irish, J.M.; Houot, Roch; Brody, Joshua; Czerwinski, Debra K; Alizadeh, Ash A.; Kolstad, Arne; Levy, Ronald.
A Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma Chain Cytokine Signaling. Blood 2009 ;Volum 114.(22) s. 316-316
OUS Untitled
 
2007
40 Cabezón, T; Celis, JE; Skibshøj, I; Klingelhöfer, J; Grigorian, M.S.; Gromov, Pavel; Rank, Fritz; Myklebust, June; Maelandsmo, Gunnhild M; Lukanidin, E.; Ambartsumian, N.
Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer. International Journal of Cancer 2007 ;Volum 121.(7) s. 1433-1444
UiO Untitled
 
41 Hystad, ME; Myklebust, JH; Bø, Trond Hellem; Bo, TH; Sivertsen, EA; Rian, E; Forfang, L; Munthe, E; Rosenwald, A; Chiorazzi, M; Jonassen, Inge; Staudt, LM; Smeland, E.B..
Characterization of early stages of human B cell development by gene expression profiling. Journal of Immunology 2007 ;Volum 179. s. 3662-3671
NORCE OUS UiB UiO Untitled
 
42 Sivertsen, Einar; Huse, Kanutte; Hystad, Marit Elise; Kersten, Christian; Smeland, Erlend B; Myklebust, June.
Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat Tag cells. European Journal of Immunology 2007 ;Volum 37.(10) s. 2937-2948
DIAKON OUS UiO Untitled
 
2006
43 Kersten, Christian; Dosen, Guri; Myklebust, June; Sivertsen, Einar; Hystad, Marit Elise; Smeland, Erlend B; Rian, Edith.
BMP-6 inhibits human bone marrow B lymphopoiesis - Upregulation of Id1 and Id3. Experimental Hematology 2006 ;Volum 34.(1) s. 72-81
OUS UiO Untitled
 
44 Sivertsen, Einar Andreas; Hystad, Marit Elise; Gutzkow, Kristine B; Døsen, Guri; Smeland, Erlend B; Blomhoff, Heidi Kiil; Myklebust, June.
PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells. British Journal of Haematology 2006 ;Volum 135.(1) s. 117-128
UiO Untitled
 
2005
45 Kersten, Christian; Sivertsen, Einar; Hystad, Marit Elise; Forfang, Lise; Smeland, Erlend B; Myklebust, June.
BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1. BMC Immunology 2005 ;Volum 6. s. 9-
OUS UiO Untitled
 
46 Torlakovic, Emina; Malecka, A; Aasheim, HC; Tierens, Anne; Nesland, Jahn M; Smeland, Erlend B; Kvaløy, Stein; Myklebust, June; Delabie, Jan.
PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: Identification of PU.1 putative binding sites in the BCL-6 promotor. Journal of Pathology 2005 ;Volum 206. s. 312-319
OUS UiO Untitled
 
2000
47 Josefsen, Dag; Myklebust, June; Lømo, Jon; Sioud, Mouldy; Blomhoff, Heidi Kiil; Smeland, Erlend B.
Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells. Stem Cells 2000 ;Volum 18.(4) s. 261-272
OUS UiO Untitled
 
1996
48 Jacobsen, Sten Eirik W.; Veiby, Ole-Petter; Myklebust, June; Okkenhaug, Cecilie; Lyman, S..
Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha. Blood 1996 ;Volum 87.(12) s. 5016-5026
UiO Untitled
 
1995
49 Jacobsen, Sten Eirik W.; Okkenhaug, Cecilie; Myklebust, June; Veiby, Ole-Petter; Lyman, S..
The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. Journal of Experimental Medicine 1995 ;Volum 181.(4) s. 1357-1363
UiO Untitled